The farm owner
Wants the herd healthy and the cost down.
AgroInsights · AgroHealthAI
AgroHealthAI is clinical decision support built for the vet — so one farm visit a day becomes five-to-ten farms monitored in real time. The farmer gets earlier, better-informed care, through their own vet.
The farmer problem underneath
Visits are reactive and cost roughly £150–300, arriving once the problem is visible — when it’s already expensive. Sub-clinical signals build in animals no one had time to check. Late detection means higher cost, mortality, blanket broad-spectrum antibiotics and lost yield.
AgroHealthAI answers that by extending the vet’s reach and evidence — not replacing them. The vet sees the reasoning, not just the answer.
What the farmer gets
The goal is lead time — catching sub-clinical signals before they present, so the vet can act before the herd is affected.
Antibiotics aimed where they’re needed — aligned to the UK 5-Year AMR National Action Plan and the EU 2030 reduction target.
From one farm visit a day to five-to-ten farms monitored in real time — the vet-capacity multiplier.
Auditable stewardship and provenance, anchored on the verified-provenance rail.
Who’s around the animal
Wants the herd healthy and the cost down.
Wants the operation protected.
Wants reach, evidence, and to act before the herd is affected.
Designed for clinicians
Every output is grounded in a peer-reviewed knowledge base and shows its sources — Bayesian-calibrated confidence, ensemble-validated across model tiers.
A ranked differential across thirteen species, surfaced in under two seconds for the vet to weigh (response speed — not a guarantee of clinical correctness). The vet makes the diagnosis.
Delivered where the vet and farmer already work, in plain language, in EN / ES / PT.
The hardware roadmap
AgroHealthAI is extending into ISF biosensors — interstitial-fluid sensors that monitor animal health continuously, in the animal. The goal is lead time: catching sub-clinical signals before they present. Patent-pending; not yet commercially available.
Design targets, not measured results: sensor detachment under 3% over a 14-day wear cycle is a simulation target; the bovine ISF correlation sub-study (n ≥ 30) is the work built to establish the real lead-times. v1 commercial launch target Q3 2027.
Our research extends to a next-generation, reagentless extended-wear biosensing approach — patent-pending — for longer-lasting, lower-maintenance monitoring. We don’t over-specify the science before it’s proven.
See the ISF roadmap ›Vet-validated, research-backed
Aidan Coe BVetMed(Hons) MRCVS, Director of Fram Farm Vets in Framlingham, is our veterinary adviser and lead vet, backing an 18-month field-validation study. We’re convening a Vet AI Advisory Council — seats are in formation and named members will be confirmed as they join.
A commercial contract with a major European veterinary group is in discussion — target Q4 2026. It is not yet signed, and we don’t present it as such.
Request a sample differential on an anonymised case, or talk to us about clinical access for your practice. The vet makes the diagnosis — AgroHealthAI supports it.
Predict. Prevent. Grow.